Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

26 juin 2017 09h01 HE | Source: Prevacus, Inc.

Prevacus Inc., Announces the Addition of Randy Travis to its Advisory Board

TALLAHASSEE, Fla., June 26, 2017 (GLOBE NEWSWIRE) -- Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and...
22 févr. 2017 10h15 HE | Source: Prevacus, Inc.

Prevacus Announces the Addition of Key Individuals to its Sports Advisory Board

TALLAHASSEE, Fla., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and...
15 févr. 2017 08h00 HE | Source: Prevacus, Inc.

Prevacus Announces Appearance on Fox Business

TALLAHASSEE, Fla., Feb. 15, 2017 (GLOBE NEWSWIRE) -- Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and...
09 févr. 2017 16h01 HE | Source: Prevacus, Inc.

Prevacus to Begin Phase 1 Clinical Studies of PRV-002 for the Treatment of Concussion

TALLAHASSEE, Fla., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion aka mild Traumatic Brain Injury (mTBI) and...